SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : VVUS: VIVUS INC. (NASDAQ)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: JFD who wrote (5510)2/19/1998 12:30:00 PM
From: Chris Delap  Read Replies (1) of 23519
 
There is a reoccurring theme that this is a PFE vs. VVUS war. Drug vs. drug. As has been said before these are two different drugs for different target audiences. I think that IN THE LONG RUN both companies will have success with their respective drugs. My investment, in VVUS, is targeted at a turn around stock. PFE is not currently in that position. I think there may be less risk with PFE but there is potentially more reward with VVUS. This is an investment strategy, I have faith that the drugs perform as described for the conditions for which they are indicated.

Ask any Pharmacist or MD all drugs have side effects.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News